Coastal Investment Advisors, Inc. Halozyme Therapeutics, Inc. Transaction History

Coastal Investment Advisors, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 05, 2020	SELL	$14.93 - $19.53 $122,052 - $159,657	-8,175 Closed	0 $0
Q3 2019 Oct 18, 2019	SELL	$15.2 - $17.69 $57,760 - $67,222	-3,800 Reduced 31.73%	8,175 $128,000
Q2 2019 Aug 01, 2019	SELL	$14.75 - $17.26 $6,637 - $7,767	-450 Reduced 3.62%	11,975 $204,000
Q1 2019 May 15, 2019	BUY	$13.94 - $17.58 $173,204 - $218,431	12,425 New	12,425 $201,000

542

125M

294K

180K

Ticker HALO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 139,288,992
Market Cap $7.49B
Description
Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...

Get notified when there are updates to the investment portfolio of Coastal Investment Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Coastal Investment Advisors, Inc. with notifications on news.